Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Geelen (Maastricht, Netherlands). Oral Presentation: Infection-related exacerbations of COPD patients. the bug or the body?. Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease

Member's Comments

No comment yet.

Related content which might interest you: Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Readmissions in COPD: The perspective of the patient Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Acute exacerbation of COPD in Emergency Room: just COPD exacerbations? Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Late Breaking Abstract - Silent exacerbations: underreporting of COPD exacerbations in Poland Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients? Source: ERJ Open Res, 7 (3) 00362-2021; 10.1183/23120541.00362-2021 Year: 2021 Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Management of acute COPD exacerbations in Australia: do we follow the guidelines? Source: ERJ Open Res, 6 (2) 00270-2019; 10.1183/23120541.00270-2019 Year: 2020 Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: Fact or fiction? Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 Factors associated with the length of hospital stay in patients with acute exacerbations of asthma and COPD overlap syndrome Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Mortality and readmissions in patients with severe COPD. Validation of the CODEX index Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 COPD patients may suffer from frequent exacerbations but mostly do not - Subpopulations of a real life survey in more than 1.700 patients Source: International Congress 2014 – COPD exacerbations Year: 2014 Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 COPD exacerbations occur more frequently in women – Data from the Bergmannsheil cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<% Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Evolution and prognosis of patients with Asthma or COPD hospitalized by COVID-19 infection. Diferences between them and the patients without airway pathology. Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021